Cargando…

Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells

There is an increasing prevalence of Alzheimer’s disease (AD), which has become a public health issue. However, the underlying mechanisms for the pathogenesis of AD are not fully understood, and the current therapeutic drugs cannot produce acceptable efficacy in AD patients. Previous animal studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li-Fang, Zhou, Zhi-Wei, Wang, Zhen-Hai, Du, Yan-Hui, He, Zhi-Xu, Cao, Chuanhai, Zhou, Shu-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284031/
https://www.ncbi.nlm.nih.gov/pubmed/25565776
http://dx.doi.org/10.2147/DDDT.S71106
_version_ 1782351362955149312
author Zhang, Li-Fang
Zhou, Zhi-Wei
Wang, Zhen-Hai
Du, Yan-Hui
He, Zhi-Xu
Cao, Chuanhai
Zhou, Shu-Feng
author_facet Zhang, Li-Fang
Zhou, Zhi-Wei
Wang, Zhen-Hai
Du, Yan-Hui
He, Zhi-Xu
Cao, Chuanhai
Zhou, Shu-Feng
author_sort Zhang, Li-Fang
collection PubMed
description There is an increasing prevalence of Alzheimer’s disease (AD), which has become a public health issue. However, the underlying mechanisms for the pathogenesis of AD are not fully understood, and the current therapeutic drugs cannot produce acceptable efficacy in AD patients. Previous animal studies have shown that coffee (Coff), caffeine (Caff), and melatonin (Mel) have beneficial effects on AD. Disturbed circadian rhythms are observed in AD, and chronotherapy has shown promising effects on AD. In this study, we examined whether a combination of Coff or Caff plus Mel produced a synergistic/additive effect on amyloid-β (Aβ) generation in Neuro-2a (N2a)/amyloid precursor protein (APP) cells and the possible mechanisms involved. Cells were treated with Coff or Caff, with or without combined Mel, with three different chronological regimens. In regimen 1, cells were treated with Coff or Caff for 12 hours in the day, followed by Mel for 12 hours in the night. For regimen 2, cells were treated with Coff or Caff plus Mel for 24 hours, from 7 am to 7 am the next day. In regimen 3, cells were treated with Coff or Caff plus Mel with regimen 1 or 2 for 5 consecutive days. The extracellular Aβ40/42 and Aβ oligomer levels were determined using enzyme-linked immunosorbent assay (ELISA) kits. The expression and/or phosphorylation levels of glycogen synthase kinase 3β (GSK3β), Erk1/2, PI3K, Akt, Tau, Wnt3α, β-catenin, and Nrf2 were detected by Western blot assay. The results showed that regimen 1 produced an additive antiamyloidogenic effect with significantly reduced extracellular levels of Aβ40/42 and Aβ42 oligomers. Regimen 2 did not result in remarkable effects, and regimen 3 showed a less antiamyloidogenic effect compared to regimen 1. Coff or Caff, plus Mel reduced oxidative stress in N2a/APP cells via the Nrf2 pathway. Coff or Caff, plus Mel inhibited GSK3β, Akt, PI3K p55, and Tau phosphorylation but enhanced PI3K p85 and Erk1/2 phosphorylation in N2a/APP cells. Coff or Caff, plus Mel downregulated Wnt3α expression but upregulated β-catenin. However, Coff or Caff plus Mel did not significantly alter the production of T helper cell (Th)1-related interleukin (IL)-12 and interferon (IFN)-γ and Th2-related IL-4 and IL-10 in N2a/APP cells. The autophagy of cells was not affected by the combinations. Taken together, combination of Caff or Coff, before treatment with Mel elicits an additive antiamyloidogenic effects in N2a/APP cells, probably through inhibition of Aβ oligomerization and modulation of the Akt/GSK3β/Tau signaling pathway.
format Online
Article
Text
id pubmed-4284031
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42840312015-01-06 Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells Zhang, Li-Fang Zhou, Zhi-Wei Wang, Zhen-Hai Du, Yan-Hui He, Zhi-Xu Cao, Chuanhai Zhou, Shu-Feng Drug Des Devel Ther Original Research There is an increasing prevalence of Alzheimer’s disease (AD), which has become a public health issue. However, the underlying mechanisms for the pathogenesis of AD are not fully understood, and the current therapeutic drugs cannot produce acceptable efficacy in AD patients. Previous animal studies have shown that coffee (Coff), caffeine (Caff), and melatonin (Mel) have beneficial effects on AD. Disturbed circadian rhythms are observed in AD, and chronotherapy has shown promising effects on AD. In this study, we examined whether a combination of Coff or Caff plus Mel produced a synergistic/additive effect on amyloid-β (Aβ) generation in Neuro-2a (N2a)/amyloid precursor protein (APP) cells and the possible mechanisms involved. Cells were treated with Coff or Caff, with or without combined Mel, with three different chronological regimens. In regimen 1, cells were treated with Coff or Caff for 12 hours in the day, followed by Mel for 12 hours in the night. For regimen 2, cells were treated with Coff or Caff plus Mel for 24 hours, from 7 am to 7 am the next day. In regimen 3, cells were treated with Coff or Caff plus Mel with regimen 1 or 2 for 5 consecutive days. The extracellular Aβ40/42 and Aβ oligomer levels were determined using enzyme-linked immunosorbent assay (ELISA) kits. The expression and/or phosphorylation levels of glycogen synthase kinase 3β (GSK3β), Erk1/2, PI3K, Akt, Tau, Wnt3α, β-catenin, and Nrf2 were detected by Western blot assay. The results showed that regimen 1 produced an additive antiamyloidogenic effect with significantly reduced extracellular levels of Aβ40/42 and Aβ42 oligomers. Regimen 2 did not result in remarkable effects, and regimen 3 showed a less antiamyloidogenic effect compared to regimen 1. Coff or Caff, plus Mel reduced oxidative stress in N2a/APP cells via the Nrf2 pathway. Coff or Caff, plus Mel inhibited GSK3β, Akt, PI3K p55, and Tau phosphorylation but enhanced PI3K p85 and Erk1/2 phosphorylation in N2a/APP cells. Coff or Caff, plus Mel downregulated Wnt3α expression but upregulated β-catenin. However, Coff or Caff plus Mel did not significantly alter the production of T helper cell (Th)1-related interleukin (IL)-12 and interferon (IFN)-γ and Th2-related IL-4 and IL-10 in N2a/APP cells. The autophagy of cells was not affected by the combinations. Taken together, combination of Caff or Coff, before treatment with Mel elicits an additive antiamyloidogenic effects in N2a/APP cells, probably through inhibition of Aβ oligomerization and modulation of the Akt/GSK3β/Tau signaling pathway. Dove Medical Press 2014-12-24 /pmc/articles/PMC4284031/ /pubmed/25565776 http://dx.doi.org/10.2147/DDDT.S71106 Text en © 2015 Zhang et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zhang, Li-Fang
Zhou, Zhi-Wei
Wang, Zhen-Hai
Du, Yan-Hui
He, Zhi-Xu
Cao, Chuanhai
Zhou, Shu-Feng
Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells
title Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells
title_full Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells
title_fullStr Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells
title_full_unstemmed Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells
title_short Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells
title_sort coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of aβ oligomerization and modulation of the tau-mediated pathway in n2a/app cells
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284031/
https://www.ncbi.nlm.nih.gov/pubmed/25565776
http://dx.doi.org/10.2147/DDDT.S71106
work_keys_str_mv AT zhanglifang coffeeandcaffeinepotentiatetheantiamyloidogenicactivityofmelatoninviainhibitionofaboligomerizationandmodulationofthetaumediatedpathwayinn2aappcells
AT zhouzhiwei coffeeandcaffeinepotentiatetheantiamyloidogenicactivityofmelatoninviainhibitionofaboligomerizationandmodulationofthetaumediatedpathwayinn2aappcells
AT wangzhenhai coffeeandcaffeinepotentiatetheantiamyloidogenicactivityofmelatoninviainhibitionofaboligomerizationandmodulationofthetaumediatedpathwayinn2aappcells
AT duyanhui coffeeandcaffeinepotentiatetheantiamyloidogenicactivityofmelatoninviainhibitionofaboligomerizationandmodulationofthetaumediatedpathwayinn2aappcells
AT hezhixu coffeeandcaffeinepotentiatetheantiamyloidogenicactivityofmelatoninviainhibitionofaboligomerizationandmodulationofthetaumediatedpathwayinn2aappcells
AT caochuanhai coffeeandcaffeinepotentiatetheantiamyloidogenicactivityofmelatoninviainhibitionofaboligomerizationandmodulationofthetaumediatedpathwayinn2aappcells
AT zhoushufeng coffeeandcaffeinepotentiatetheantiamyloidogenicactivityofmelatoninviainhibitionofaboligomerizationandmodulationofthetaumediatedpathwayinn2aappcells